Owner Minerva Biotechnologies Corporation

Inventors Bamdad, Cynthia C.

Agent Freehills

Pub. Number AU-B-2004267112

PCT Pub. Number WO2005/019269

Priority 60/498,260 26.08.03 US

Parent 2002243251

Filing date 26 August 2004

Wipo publication date 3 March 2005

Acceptance publication date 11 June 2009

A61P 35/00 (2006.01) Antineoplastic agents

A61K 31/198 (2006.01)

A61K 31/336 (2006.01) - having three-membered rings, e.g. oxirane, fumagillin

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 27/447 (2006.01) Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means - using electrophoresis

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer